Geneos Wealth Management Inc. Boosts Stock Holdings in Danaher Corporation (NYSE:DHR)

Geneos Wealth Management Inc. grew its holdings in Danaher Corporation (NYSE:DHR - Free Report) by 80.8% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 30,214 shares of the conglomerate's stock after purchasing an additional 13,501 shares during the quarter. Geneos Wealth Management Inc.'s holdings in Danaher were worth $6,194,000 as of its most recent SEC filing.

Other institutional investors have also bought and sold shares of the company. FAS Wealth Partners Inc. increased its holdings in Danaher by 20.6% in the 4th quarter. FAS Wealth Partners Inc. now owns 9,597 shares of the conglomerate's stock valued at $2,203,000 after purchasing an additional 1,639 shares during the last quarter. Asahi Life Asset Management CO. LTD. acquired a new stake in Danaher in the 1st quarter valued at approximately $539,000. Horizon Financial Services LLC increased its holdings in Danaher by 20,400.0% in the 1st quarter. Horizon Financial Services LLC now owns 8,200 shares of the conglomerate's stock valued at $1,681,000 after purchasing an additional 8,160 shares during the last quarter. Vision Capital Management Inc. acquired a new stake in Danaher in the 1st quarter valued at approximately $461,000. Finally, Eos Management L.P. grew its stake in shares of Danaher by 55.8% in the first quarter. Eos Management L.P. now owns 40,567 shares of the conglomerate's stock worth $8,316,000 after acquiring an additional 14,537 shares in the last quarter. 79.05% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

DHR has been the subject of several research reports. Jefferies Financial Group dropped their price target on shares of Danaher from $260.00 to $230.00 and set a "buy" rating for the company in a research note on Tuesday, April 22nd. Deutsche Bank Aktiengesellschaft dropped their price target on shares of Danaher from $240.00 to $235.00 in a research note on Thursday, June 5th. Leerink Partners boosted their price target on shares of Danaher from $225.00 to $230.00 and gave the stock an "outperform" rating in a research note on Wednesday, April 23rd. Evercore ISI dropped their price target on shares of Danaher from $230.00 to $226.00 and set an "outperform" rating for the company in a research note on Tuesday, July 8th. Finally, Bank of America dropped their price target on shares of Danaher from $265.00 to $230.00 in a research note on Monday, April 14th. Three research analysts have rated the stock with a hold rating and eighteen have assigned a buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $247.61.

Insider Activity at Danaher

In other news, Chairman Steven M. Rales sold 1,250,000 shares of the company's stock in a transaction dated Monday, May 12th. The shares were sold at an average price of $196.74, for a total value of $245,925,000.00. Following the completion of the sale, the chairman directly owned 3,105,808 shares of the company's stock, valued at approximately $611,036,665.92. This represents a 28.70% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 11.10% of the company's stock.

Danaher Stock Performance

DHR traded down $0.08 on Friday, reaching $197.08. The company had a trading volume of 5,736,543 shares, compared to its average volume of 4,315,577. The stock has a 50-day moving average price of $197.25 and a 200-day moving average price of $202.96. Danaher Corporation has a 1 year low of $171.00 and a 1 year high of $279.90. The company has a quick ratio of 1.22, a current ratio of 1.62 and a debt-to-equity ratio of 0.32. The stock has a market capitalization of $141.12 billion, a PE ratio of 41.93, a P/E/G ratio of 2.83 and a beta of 0.77.

Danaher (NYSE:DHR - Get Free Report) last announced its earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 EPS for the quarter, beating analysts' consensus estimates of $1.64 by $0.16. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The business had revenue of $5.94 billion during the quarter, compared to analysts' expectations of $5.83 billion. During the same period in the prior year, the company earned $1.72 earnings per share. The business's revenue was up 3.4% compared to the same quarter last year. As a group, research analysts forecast that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, July 25th. Stockholders of record on Friday, June 27th were issued a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.6%. Danaher's payout ratio is 27.23%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.